LuciAbro 100mg,(Abrocitinib)
LuciAbe 50mg,(Abemaciclib)
LuciAbe 50mg, Abemaciclib Tablets $450
Back to products
LuciAcal 100mg,(Acalabrutinib)
LuciAcal 100mg, Acalabrutinib Capsules $420

LuciAbro 100mg, Abrocitinib Tablets

$110

Compare
Category: Tag:
Description

LuciAbro 100mg, Abrocitinib Tablets

Adults and adolescents 12 years of age and older with moderate to severe atopic dermatitis (eczema) can be treated with LuciAbro 100mg, an oral medicine that contains the selective JAK1 inhibitor abrocitinib.It offers a targeted approach to reduce inflammation, itching, and flare-ups in patients who do not respond adequately to topical treatments. LuciAbro provides an effective systemic option to improve skin condition and quality of life in chronic eczema sufferers.

What is LuciAbro 100mg (Abrocitinib)?

JAK1 enzymes, which are implicated in the signaling pathways of immunological and inflammatory responses, are inhibited by abrocitinib. It is primarily prescribed for the treatment of moderate to severe atopic dermatitis (AD), also known as eczema, in adults and adolescents aged 12 years and older. While topical treatments are effective for many, patients with more severe disease may need systemic therapies like LuciAbro.

Approved by regulatory authorities for patients whose eczema is not adequately controlled with topical agents or when those treatments are not advisable, Abrocitinib offers a targeted mechanism of action that addresses the underlying causes of inflammation.

How Does LuciAbro Work?

Abrocitinib works by selectively inhibiting Janus kinase 1 (JAK1), an enzyme involved in the signaling of several inflammatory cytokines, including interleukin-4 (IL-4), IL-13, and IL-31. These cytokines play a significant role in the inflammation and itching associated with atopic dermatitis.

By blocking JAK1, abrocitinib disrupts the JAK-STAT signaling pathway, leading to reduced production of pro-inflammatory cytokines. This mechanism helps decrease inflammation and pruritus (itching), thereby improving the symptoms of atopic dermatitis.

How to Use LuciAbro 100mg

LuciAbro 100mg is administered orally and is available in tablet form. The standard recommended dosage is:

  • Take 100 mg once daily, at the same time each day.
  • Using water, swallow the tablet whole. It is not recommended to chew, break, or crush the tablet.
  • Patients should always follow their healthcare provider’s dosage instructions. Adherence to the prescribed schedule ensures maximum therapeutic benefit and minimizes potential side effects.

How to Take LuciAbro Safely

To ensure the safe and effective use of LuciAbro:

Medical Assessment: Before starting LuciAbro, your doctor will evaluate your health history, check for infections (especially tuberculosis and hepatitis), and possibly order baseline blood tests (CBC, liver function, cholesterol).

  • Monitoring: Once treatment begins, periodic lab tests are necessary to monitor
  • White blood cell and platelet counts
  • Liver enzymes (ALT, AST)
  • Blood cholesterol levels
  • Avoid Live Vaccines: Patients should not receive live vaccines while taking LuciAbro due to a potentially weakened immune response.
  • Special Populations: Caution is advised in the elderly, those with a history of blood clots, infections, or cancer, and those who are pregnant or breastfeeding.
  • dosage missing: Take the missing dosage as soon as you remember. Don’t double up; if your next dose is approaching, skip the one you missed.

Other Dosage Forms and Adjustments

While LuciAbro is commonly prescribed at 100mg, some patients may be started on or adjusted to 200mg once daily based on the severity of the condition and clinical response.

  • Dose Adjustment: Dosage may be reduced in patients with renal or hepatic impairment or if side effects occur.
  • Availability: LuciAbro comes in 100mg and 200mg tablets, allowing flexibility in therapy customization.
  • The right dose will depend on individual factors including age, weight, comorbid conditions, and response to treatment.

Side Effects of LuciAbro

Common Side Effects

These are typically small and may disappear on their own:

  • Nausea
  • Headache
  • Acne
  • Herpes simplex (cold sores)
  • Elevated cholesterol
  • Abdominal pain

Serious Side Effects

These require immediate medical attention:

  • Severe infections (e.g., pneumonia, tuberculosis)
  • Blood clots in legs or lungs
  • Low white blood cell or platelet count
  • Elevated liver enzymes
  • Reactivation of herpes zoster (shingles)

Patients should report any unusual bruising, fatigue, persistent fever, or signs of infection immediately.

Prescription Status

LuciAbro 100mg is a prescription-only medication. It must be prescribed by a licensed medical professional, typically a dermatologist or immunologist. Because of the possibility of severe adverse effects and interactions, self-medication or use without appropriate supervision is strongly advised.

Doctors may prescribe LuciAbro after assessing:

  • Failure or intolerance to topical treatments
  • Severity of skin symptoms
  • Impact on daily life and mental well-being
  • Drug Interactions

Abrocitinib may interact with several medications, which could either enhance toxicity or reduce effectiveness.

Major Interactions Include:

  • CYP2C19 inhibitors (e.g., fluconazole, omeprazole): May increase Abrocitinib levels.
  • CYP2C19 inducers (e.g., rifampicin): May reduce efficacy.
  • Immunosuppressants: May increase infection risk.
  • Anticoagulants: May increase bleeding risk.
  • Live vaccines: Should be avoided during therapy.

Always inform your doctor about all medications, including over-the-counter drugs and herbal supplements, before starting LuciAbro.

FAQs

  • What is LuciAbro 100mg used for?

LuciAbro 100mg is a prescription medication used to treat moderate to severe atopic dermatitis (eczema) in adults.

  • How long does it take for LuciAbro to show results?

Some patients report reduced itching within 1–2 weeks, with full skin improvement observed in 8–12 weeks.

  • Can LuciAbro be used in children?

It is approved for use in adolescents aged 12 years and older. Use in children under 12 is not yet established.

Conclusion

LuciAbro 100mg (Abrocitinib) is a modern, effective systemic treatment for patients with moderate to severe atopic dermatitis who do not respond adequately to topical therapies. Its targeted mechanism of action offers relief from inflammation and itching, making it a valuable option in dermatological care. 

When used responsibly under professional guidance, LuciAbro can significantly improve quality of life for those struggling with chronic eczema. Speak to your healthcare provider to determine if this medication is suitable for your condition and ensure proper monitoring during its use.